Hanall Biopharma Market Cap

Hanall Biopharma has a market cap or net worth of 1.38 trillion as of April 17, 2025. Its market cap has decreased by -28.66% in one year.

Market Cap

1.38T

Enterprise Value

1.36T

Revenue

138.94B

Ranking

n/a

PE Ratio

n/a

Stock Price

27,250.00

Market Cap Chart

Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 1.38T, an increase of 5,160.07%. That is a compound annual growth rate of 14.30%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2025	1,383.36B	-29.42%
Dec 30, 2024	1,959.95B	-12.72%
Dec 28, 2023	2,245.71B	148.89%
Dec 29, 2022	902.29B	-16.29%
Dec 30, 2021	1,077.89B	-43.84%
Dec 30, 2020	1,919.22B	3.31%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.81T
Celltrion	34.26T
ALTEOGEN	20.25T
Yuhan	8,492.29B
SK Biopharmaceuticals	8,034.94B
HLB Co., Ltd.	7,094.07B
LigaChem Biosciences	3,972.88B
PharmaResearch	3,807.81B

Market Cap Rankings